-
November 4, 2020
-
Haemonetics 2nd Quarter Fiscal Year 2021 Earnings Release Available on Investor Relations Website
View details
-
October 6, 2020
-
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2021 Results: November 4, 2020
View details
-
October 2, 2020
-
Haemonetics Receives FDA Clearance For NexSys PCS® With Persona™ Technology
View details
-
September 9, 2020
-
Haemonetics To Present At The 18th Annual Morgan Stanley Global Healthcare Conference
View details
-
August 7, 2020
-
Haemonetics Clinical Study Results On A New, Personalized Approach To Plasma Collection To Be Presented At 2020 AABB Annual Meeting
View details
-
August 4, 2020
-
Haemonetics First Quarter Fiscal 2021 Earnings Release Available on Investor Relations Website
View details
-
July 24, 2020
-
Haemonetics Announces Sale Of Inlog Holdings France SAS To Abénex Capital
View details
-
July 6, 2020
-
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2021 Results: August 4, 2020
View details
-
July 2, 2020
-
Haemonetics Statement on the Safety of Our Blood and Plasma Collection Devices
View details
-
June 30, 2020
-
Haemonetics Announces 2020 Annual Meeting Of Shareholders Will Be Conducted In Virtual Format
View details
-
June 3, 2020
-
Haemonetics Announces Blood Filter Supply Agreement And Sale Of Puerto Rico-Based Manufacturing Operations To GVS, S.p.A
View details
-
May 28, 2020
-
Haemonetics Announces Sale Of U.S. Blood Donor Management Software Solution Assets To The GPI Group
View details
-
May 6, 2020
-
Haemonetics Announces Commitment to COVID-19 Relief Efforts
View details
-
May 5, 2020
-
Haemonetics 4th Quarter and Fiscal 2020 Earnings Release Available on Investor Relations Website
View details
-
April 17, 2020
-
Michael Coyle Joins Haemonetics Board of Directors
View details
-
April 3, 2020
-
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2020 Results: May 5, 2020
View details
-
April 2, 2020
-
Haemonetics Acquires enicor GmbH to Expand Advanced Viscoelastic Testing Portfolio
View details
-
March 30, 2020
-
Haemonetics Appoints Anila Lingamneni Executive Vice President, Chief Technology Officer
View details
-
March 14, 2020
-
Haemonetics statement on business continuity in response to COVID-19
View details
-
February 4, 2020
-
Haemonetics 3rd Quarter Fiscal 2020 Earnings Release Available on Investor Relations Website
View details
-
January 14, 2020
-
Haemonetics Announces Acquisition Of Intellectual Property Assets Relating To TEG® 6s Hemostasis Analyzer System
View details